Log in

OTCMKTS:ADOCY - ADOCIA/S Stock Price, Forecast & News

0.00 (0.00 %)
(As of 01/2/2020)
Today's Range
Now: $12.38
50-Day Range
MA: $12.38
52-Week Range
Now: $12.38
Volume2 shs
Average VolumeN/A
Market Capitalization$85.67 million
P/E Ratio9.52
Dividend YieldN/A
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform is designed and developed based on novel polymers, oligomers, and small molecules to enhance the effectiveness and/or safety of therapeutic proteins. Read More…

Industry, Sector and Symbol

Industry Tobacco products



Sales & Book Value

Annual Sales$55.97 million
Cash Flow$1.48 per share
Book Value$7.82 per share



Market Cap$85.67 million
Next Earnings Date3/9/2020 (Estimated)
OptionableNot Optionable

Receive ADOCY News and Ratings via Email

Sign-up to receive the latest news and ratings for ADOCY and its competitors with MarketBeat's FREE daily newsletter.

ADOCIA/S (OTCMKTS:ADOCY) Frequently Asked Questions

What is ADOCIA/S's stock symbol?

ADOCIA/S trades on the OTCMKTS under the ticker symbol "ADOCY."

When is ADOCIA/S's next earnings date?

ADOCIA/S is scheduled to release their next quarterly earnings announcement on Monday, March 9th 2020. View Earnings Estimates for ADOCIA/S.

What is the consensus analysts' recommendation for ADOCIA/S?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ADOCIA/S in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for ADOCIA/S.

Has ADOCIA/S been receiving favorable news coverage?

News headlines about ADOCY stock have trended negative recently, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. ADOCIA/S earned a media sentiment score of -2.3 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for ADOCIA/S.

Who are some of ADOCIA/S's key competitors?

What other stocks do shareholders of ADOCIA/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ADOCIA/S investors own include Relypsa (RLYP), Innate Pharma (IPHYF), Repros Therapeutics (RPRX), Spectrum Pharmaceuticals (SPPI), Verastem (VSTM), DBV TECHNOLOGIE/S (DBVT), Epizyme (EPZM), Exelixis (EXEL), Intercept Pharmaceuticals (ICPT) and MEI Pharma (MEIP).

Who are ADOCIA/S's key executives?

ADOCIA/S's management team includes the folowing people:
  • Dr. Gérard Soula, Co-Founder, Chairman, CEO & Pres (Age 74)
  • Mr. Olivier Soula, Co-Founder, Deputy CEO, VP, Director of R&D and Director (Age 49)
  • Mr. Rémi Soula, Co-Founder, Director of Bus. Devel. & Intellectual Property and Scientific Advisor
  • Ms. Valerie Danaguezian, CFO & Admin. Director
  • Ms. Geraldine Favre Soula, HR Devel. Director

How do I buy shares of ADOCIA/S?

Shares of ADOCY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is ADOCIA/S's stock price today?

One share of ADOCY stock can currently be purchased for approximately $12.38.

How big of a company is ADOCIA/S?

ADOCIA/S has a market capitalization of $85.67 million and generates $55.97 million in revenue each year. The company earns $8.99 million in net income (profit) each year or $1.30 on an earnings per share basis. ADOCIA/S employs 132 workers across the globe.View Additional Information About ADOCIA/S.

What is ADOCIA/S's official website?

The official website for ADOCIA/S is http://www.adocia.com/.

How can I contact ADOCIA/S?

ADOCIA/S's mailing address is 115 avenue Lacassagne, Lyon I0, 69003. The company can be reached via phone at 33-04-72-61-06-10 or via email at [email protected]

MarketBeat Community Rating for ADOCIA/S (OTCMKTS ADOCY)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  96 (Thanks for Voting!)
Underperform Votes:  119 (Thanks for Voting!)
Total Votes:  215
MarketBeat's community ratings are surveys of what our community members think about ADOCIA/S and other stocks. Vote "Outperform" if you believe ADOCY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ADOCY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel